About the Authors
- Lixin Wang
-
Contributed equally to this work with: Lixin Wang, Mulugeta Million
Affiliation Division of Digestive Diseases, Department of Medicine, CURE and Center for Neurobiological Stress, David Geffen School of Medicine at University of California Los Angeles, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States of America
- Mulugeta Million
-
Contributed equally to this work with: Lixin Wang, Mulugeta Million
* E-mail: milllionmulugeta@mednet.ucla.edu
Affiliation Division of Digestive Diseases, Department of Medicine, CURE and Center for Neurobiological Stress, David Geffen School of Medicine at University of California Los Angeles, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States of America
- Jean Rivier
-
Affiliation Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, California, United States of America
- Catherine Rivier
-
Affiliation Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, California, United States of America
- Noah Craft
-
Affiliation Divisions of Dermatology and Infectious Diseases, Department of Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, David Geffen School of Medicine at University of California Los Angeles, Torrance, California, United States of America
- Mary P. Stenzel-Poore
-
Affiliation Department of Molecular Microbiology and Immunology, Oregon Health & Sciences University, Portland, Oregon, United States of America
- Yvette Taché
-
Affiliation Division of Digestive Diseases, Department of Medicine, CURE and Center for Neurobiological Stress, David Geffen School of Medicine at University of California Los Angeles, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States of America
Competing Interests
The authors have read the journal's policy and have the following conflict: JR is Founder, equity owner, President, and Chair of scientific advisory board of Sentia Medical Sciences, Inc. Sentia has an exclusive license from the Salk Institute for astressin B and analogs (US patent numbers 6,323,312, 5,874,227, 5,777,073 and 7,141,546). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MM LW YT JR NC. Performed the experiments: LW MM. Analyzed the data: MM LW CR NC. Contributed reagents/materials/analysis tools: YT JR CR MPS-P. Wrote the paper: LW MM YT JR NC. Synthetized the peptide and participated in the design of experiment: JR. Designed and generated mice and worked on manuscript: MPS-P.